Meeting
2016 Genitourinary Cancers Symposium
Assessing the frequency of somatic mutations in high-risk clear cell renal cell carcinoma to provide new perspectives.
Authors
Brandon Manley
Memorial Sloan Kettering Cancer Center, New York, NY
Brandon Manley , Daniel Tennenbaum , Jozefina Casuscelli , James Hsieh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 548)
DOI
10.1200/jco.2016.34.2_suppl.548
Abstract #
548
Poster Bd #
F9
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
PBRM1 mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.
First Author: Gennady Bratslavsky
Poster
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
First Author: Gennady Bratslavsky
Poster
2020 ASCO Virtual Scientific Program
Clinically advanced renal cell carcinoma (RCC) and renal sarcoma (RSC) in young patients: A comprehensive genomic profiling (CGP) study.
First Author: Gennady Bratslavsky
Poster
2020 ASCO Virtual Scientific Program
Comprehensive genomic profiling of 216 Chinese patients with renal cell carcinoma.
First Author: Congwang Zhang